Cardium Therapeutics is an asset-based health sciences and regenerative medicine company focused on the acquisition and strategic development of innovative products and businesses with the potential to address significant unmet medical needs and having definable pathways to commercialization, partnering or other economic monetizations. Cardium's current portfolio includes the Tissue Repair Company and Cardium Biologics, companies primarily focused on the development of innovative therapeutic products for wound healing and cardiovascular indications, and the To Go Brands healthy nutraceutical supplement business.